D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- -95.16%
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- -95.16%
Cost of Revenue 37.72% 40.86% 67.17% 71.18% 106.54%
Gross Profit -38.47% -40.86% -234.60% -90.56% -167.42%
SG&A Expenses 51.33% 54.45% 48.30% 72.70% 70.89%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 39.35% 42.57% 39.09% 71.42% 101.49%
Operating Income -40.02% -42.57% -43.98% -87.42% -150.35%
Income Before Tax -21.17% -39.17% -35.54% -70.35% -184.64%
Income Tax Expenses -319.53% -- -- -- 378.86%
Earnings from Continuing Operations -20.45% -44.13% -35.54% -70.35% -185.87%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -20.45% -44.13% -35.54% -70.35% -185.87%
EBIT -40.02% -42.57% -43.98% -87.42% -150.35%
EBITDA -40.11% -42.69% -44.12% -88.35% -152.80%
EPS Basic 2.13% 5.64% 12.28% 1.94% -80.53%
Normalized Basic EPS -16.96% 8.89% 12.28% 4.30% -51.31%
EPS Diluted 2.13% 5.64% 12.28% 1.94% -80.53%
Normalized Diluted EPS -16.96% 8.89% 12.28% 4.30% -51.31%
Average Basic Shares Outstanding 23.07% 52.74% 54.51% 73.71% 58.35%
Average Diluted Shares Outstanding 23.07% 52.74% 54.51% 73.71% 58.35%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings